Eli Lilly, Minnesota Reach Settlement in Insulin Price Case (1)

Eli Lilly & Co. has agreed to offer its insulin products at no more than $35 per month to any Minnesota resident with a valid prescription, according to the terms of a proposed settlement filed Wednesday in a case over insulin pricing dating back to 2018.

The settlement, filed in the US District Court for the District of New Jersey, would hold Lilly to this cost for Minnesotans for five years after the agreement goes into effect.

As part of the agreement, Lilly must have a feature on its website allowing customers to receive electronically any coupon, copayment card, ...